Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

62.5%

5 terminated/withdrawn out of 8 trials

Success Rate

28.6%

-57.9% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1

3(50.0%)

Phase 2

2(33.3%)

Phase 3

1(16.7%)

6Total

Phase 1(3)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03735095Phase 1Terminated

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Role: collaborator

NCT01966809Phase 2Terminated

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Role: collaborator

NCT01682746Phase 1Completed

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Role: collaborator

NCT01770132Phase 1Completed

Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Role: collaborator

NCT01842555Unknown

Photodynamic Therapy (PDT) Oncology Registry

Role: collaborator

NCT01256203Phase 2Withdrawn

Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light

Role: lead

NCT01203163Withdrawn

Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes

Role: lead

NCT01209013Phase 3Withdrawn

Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE)

Role: lead

All 8 trials loaded